Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Text availability
Article attribute
Article type
Publication date

Search Results

29 results
Filters applied: . Clear all Results are displayed in a computed author sort order. Results by year timeline is unavailable
Page 1
Inhibition of carcinogenesis by tea.
Yang CS, Maliakal P, Meng X. Yang CS, et al. Annu Rev Pharmacol Toxicol. 2002;42:25-54. doi: 10.1146/annurev.pharmtox.42.082101.154309. Annu Rev Pharmacol Toxicol. 2002. PMID: 11807163 Review.
Delivery of tea polyphenols to the oral cavity by green tea leaves and black tea extract.
Lee MJ, Lambert JD, Prabhu S, Meng X, Lu H, Maliakal P, Ho CT, Yang CS. Lee MJ, et al. Cancer Epidemiol Biomarkers Prev. 2004 Jan;13(1):132-7. doi: 10.1158/1055-9965.epi-03-0040. Cancer Epidemiol Biomarkers Prev. 2004. PMID: 14744744 Clinical Trial.
Pharmacokinetics of tea catechins after ingestion of green tea and (-)-epigallocatechin-3-gallate by humans: formation of different metabolites and individual variability.
Lee MJ, Maliakal P, Chen L, Meng X, Bondoc FY, Prabhu S, Lambert G, Mohr S, Yang CS. Lee MJ, et al. Cancer Epidemiol Biomarkers Prev. 2002 Oct;11(10 Pt 1):1025-32. Cancer Epidemiol Biomarkers Prev. 2002. PMID: 12376503
Tea consumption modulates hepatic drug metabolizing enzymes in Wistar rats.
Maliakal PP, Coville PF, Wanwimolruk S. Maliakal PP, et al. J Pharm Pharmacol. 2001 Apr;53(4):569-77. doi: 10.1211/0022357011775695. J Pharm Pharmacol. 2001. PMID: 11341376

CYP 1A2 activity was markedly increased in all the tea treatment groups (P < 0.05). CYP 1A1 activity was increased significantly in most of the groups except for the Madura, Gunpowder, and Java green tea-treatment groups. Cytosolic glutathione-S-transferase activity was

CYP 1A2 activity was markedly increased in all the tea treatment groups (P < 0.05). CYP 1A1 activity was increased significantly i

Sacituzumab govitecan (IMMU-132), an anti-Trop-2-SN-38 antibody-drug conjugate for the treatment of diverse epithelial cancers: Safety and pharmacokinetics.
Ocean AJ, Starodub AN, Bardia A, Vahdat LT, Isakoff SJ, Guarino M, Messersmith WA, Picozzi VJ, Mayer IA, Wegener WA, Maliakal P, Govindan SV, Sharkey RM, Goldenberg DM. Ocean AJ, et al. Among authors: maliakal p. Cancer. 2017 Oct 1;123(19):3843-3854. doi: 10.1002/cncr.30789. Epub 2017 May 30. Cancer. 2017. PMID: 28558150 Free article. Clinical Trial.
Tolfenamic acid suppresses cytochrome P450 2E1 expression in mouse liver.
Shukoor MI, Tiwari S, Sankpal UT, Maliakal P, Connelly SF, Siddiqi S, Siddiqi SA, Basha R. Shukoor MI, et al. Integr Biol (Camb). 2012 Sep;4(9):1122-9. doi: 10.1039/c2ib20127e. Epub 2012 Jul 26. Integr Biol (Camb). 2012. PMID: 22832660 Free PMC article.
Environmental factors in causing human cancers: emphasis on tumorigenesis.
Sankpal UT, Pius H, Khan M, Shukoor MI, Maliakal P, Lee CM, Abdelrahim M, Connelly SF, Basha R. Sankpal UT, et al. Tumour Biol. 2012 Oct;33(5):1265-74. doi: 10.1007/s13277-012-0413-4. Epub 2012 May 22. Tumour Biol. 2012. PMID: 22614680 Review.
29 results
Jump to page
Feedback